186 related articles for article (PubMed ID: 18263559)
1. The value of implementation and the value of information: combined and uneven development.
Fenwick E; Claxton K; Sculpher M
Med Decis Making; 2008; 28(1):21-32. PubMed ID: 18263559
[TBL] [Abstract][Full Text] [Related]
2. Value of information and value of implementation: application of an analytic framework to inform resource allocation decisions in metastatic hormone-refractory prostate cancer.
Hoomans T; Fenwick EA; Palmer S; Claxton K
Value Health; 2009; 12(2):315-24. PubMed ID: 18657098
[TBL] [Abstract][Full Text] [Related]
3. How to Invest in Getting Cost-effective Technologies into Practice? A Framework for Value of Implementation Analysis Applied to Novel Oral Anticoagulants.
Faria R; Walker S; Whyte S; Dixon S; Palmer S; Sculpher M
Med Decis Making; 2017 Feb; 37(2):148-161. PubMed ID: 27105651
[TBL] [Abstract][Full Text] [Related]
4. Optimal Allocation of Research Funds under a Budget Constraint.
Fairley M; Cipriano LE; Goldhaber-Fiebert JD
Med Decis Making; 2020 Aug; 40(6):797-814. PubMed ID: 32845233
[No Abstract] [Full Text] [Related]
5. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
[TBL] [Abstract][Full Text] [Related]
6. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence.
Siebert U; Rochau U; Claxton K
Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327
[TBL] [Abstract][Full Text] [Related]
7. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.
Devlin N; Parkin D
Health Econ; 2004 May; 13(5):437-52. PubMed ID: 15127424
[TBL] [Abstract][Full Text] [Related]
8. A new approach for sample size calculation in cost-effectiveness studies based on value of information.
Bader C; Cossin S; Maillard A; Bénard A
BMC Med Res Methodol; 2018 Oct; 18(1):113. PubMed ID: 30348087
[TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
10. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
[TBL] [Abstract][Full Text] [Related]
11. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
Williams I; McIver S; Moore D; Bryan S
Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
[TBL] [Abstract][Full Text] [Related]
12. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.
Claxton K
J Health Econ; 1999 Jun; 18(3):341-64. PubMed ID: 10537899
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
Robinson M; Palmer S; Sculpher M; Philips Z; Ginnelly L; Bowens A; Golder S; Alfakih K; Bakhai A; Packham C; Cooper N; Abrams K; Eastwood A; Pearman A; Flather M; Gray D; Hall A
Health Technol Assess; 2005 Jul; 9(27):iii-iv, ix-xi, 1-158. PubMed ID: 16022802
[TBL] [Abstract][Full Text] [Related]
14. The NICE cost-effectiveness threshold: what it is and what that means.
McCabe C; Claxton K; Culyer AJ
Pharmacoeconomics; 2008; 26(9):733-44. PubMed ID: 18767894
[TBL] [Abstract][Full Text] [Related]
15. Subcategorizing the Expected Value of Perfect Implementation to Identify When and Where to Invest in Implementation Initiatives.
Johannesen K; Janzon M; Jernberg T; Henriksson M
Med Decis Making; 2020 Apr; 40(3):327-338. PubMed ID: 32133911
[No Abstract] [Full Text] [Related]
16. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
17. Adjusting Estimates of the Expected Value of Information for Implementation: Theoretical Framework and Practical Application.
Andronis L; Barton PM
Med Decis Making; 2016 Apr; 36(3):296-307. PubMed ID: 26566775
[TBL] [Abstract][Full Text] [Related]
18. Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations.
Franklin M; Lomas J; Richardson G
Pharmacoeconomics; 2020 Jul; 38(7):665-681. PubMed ID: 32291596
[TBL] [Abstract][Full Text] [Related]
19. Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods.
Groot Koerkamp B; Myriam Hunink MG; Stijnen T; Weinstein MC
Health Econ; 2006 Apr; 15(4):383-92. PubMed ID: 16389669
[TBL] [Abstract][Full Text] [Related]
20. Implementing guidelines into clinical practice: what is the value?
Hoomans T; Ament AJ; Evers SM; Severens JL
J Eval Clin Pract; 2011 Aug; 17(4):606-14. PubMed ID: 21029273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
